http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20050002872-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
filingDate | 2003-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2005-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20050002872-A |
titleOfInvention | Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
abstract | In the present invention, the monoclinic space group has P 2 1 , the crystal axis length is a = 15.5-17.0 mm, b = 15.5-17.0 mm and c = 17.5-19.5 mm, and the angle between the crystal axes is α = γ = 90 ° and Regarding the analogous polymorph of homologous structure of substantially pure 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A represented by the following formula (I) with an average unit cell variable with β = 106-112 ° Will.n n n n n n n n Wherein S is an organic solvent that is at least partially water miscible, x is 1, 1.25, 1.5, or 2, and y is 0, 0.5, or 1. The present invention also provides a process for preparing a pseudo polymorph of substantially pure homologous structure of formula (I), a pharmaceutical composition comprising a substantially pure homologous structure of homogeneous structure of formula (I) and a substantially pure homologous structure of formula (I) A method of treating bacterial and protozoal infections and inflammation related diseases by administering pharmaceutical compositions containing analogous polymorphs. |
priorityDate | 2002-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.